New user? / Forgot your password?
0 Item | 0,00 €
Item number | 676364 |
CAS | 693-98-1 |
Formula | C4H6N2 |
Molecular weight | 82,10 g/mol |
Quantity | 1X100MG |
storage conditions | 4 °C |
CoA / MSDS | Retrieve CoA Retrieve MSDS |
Product | Catalog No./ CAS No. | Quantity | Price | |
---|---|---|---|---|
1-Methylimidazole solution | 687725 | 1X1ML | Please log in. | |
691686 | 1X250MG | Please log in. | ||
691024 | 1X10MG | Please log in. | ||
13C2,15N2-2-Methylimidazole solution | 691083 | 1X1ML | ||
676364 | 1X100MG | Please log in. | ||
676223 | 1X100MG | Please log in. | ||
687121 | 1X10MG | Please log in. |
Safety Data Sheet | according to Regulation (EC) No 1907/2006 (REACH) Classifications according to Regulation (EC) No 1272/2008. Printdate 26.12.2024 |
IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING | |
Product name: | 2-Methylimidazole |
Catalog No.: | 676364 |
Relevant identified uses of the substance or mixture | Identified: Laboratory chemical uses: R&D |
Uses advised against: | HPC Standards GmbH Am Wieseneck 7 04451 Cunnersdorf Deutschland Tel. +49 34291 3372-36 Fax. +49 34291 3372-39 contact@hpc-standards.com |
Emergency telephone number | HPC Standards Tel. +49 34291 3372-36 This number is only available during office hours. |
HAZARDS IDENTIFICATION | 2.1 Classification of the substance or mixture Classification according to Regulation (EC) No 1272/2008 Acute toxicity, Oral (Category 4), H302 Skin corrosion (Category 1C), H314 Carcinogenicity (Category 2), H351 Reproductive toxicity (Category 1B), H360 Classification according to EU Directives 67/548/EEC or 1999/45/EC T Toxic R22, R34, R40, R61 |
Label elements | |
Pictogram | GHS05 acid acid GHS07 exclam exclam GHS08 silhouete silhouete |
2.2 Label elements Labelling according Regulation (EC) No 1272/2008 Pictogram Signal word Danger Hazard statement(s) H302 Harmful if swallowed. H314 Causes severe skin burns and eye damage. H351 Suspected of causing cancer. H360 May damage fertility or the unborn child. Precautionary statement(s) P201 Obtain special instructions before use. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P303 + P361 + P353 IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water/shower. P304 + P340 + P310 IF INHALED: Remove person to fresh air and keep comfortable for breathing. Immediately call a POISON CENTER or doctor/ physician. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P308 + P313 IF exposed or concerned: Get medical advice/ attention. Supplemental Hazard Statements none Restricted to professional users. 2.3 Other hazards This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher. | |
COMPOSITION/INFORMATION ON INGREDIENTS | 3.1 Substances Synonyms : 2-Methylglyoxaline Formula : C4H6N2 Molecular weight : 82,10 g/mol CAS-No. : 693-98-1 EC-No. : 211-765-7 Hazardous ingredients according to Regulation (EC) No 1272/2008 Component Classification Concentration 2-Methylimidazole CAS-No. EC-No. 693-98-1 211-765-7 Acute Tox. 4; Skin Corr. 1C; Carc. 2; Repr. 1B; H302, H314, H351, H360 <= 100 % Hazardous ingredients according to Directive 1999/45/EC Component Classification Concentration 2-Methylimidazole CAS-No. EC-No. 693-98-1 211-765-7 T, R22 - R34 - R40 - R61 <= 100 % |
Formula | C4H6N2 |
Molecular Weight (g/mol) | 82.10 |
CAS-No. | 693-98-1 |
FIRST AID MEASURES | 4.1 Description of first aid measures General advice Consult a physician. Show this safety data sheet to the doctor in attendance. If inhaled If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician In case of skin contact Take off contaminated clothing and shoes immediately. Wash off with soap and plenty of water. Consult a physician. In case of eye contact Rinse thoroughly with plenty of water for at least 15 minutes and consult a physician. If swallowed Do NOT induce vomiting. Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician. 4.2 Most important symptoms and effects, both acute and delayed The most important known symptoms and effects are described in the labelling (see section 2.2) and/or in section 11 4.3 Indication of any immediate medical attention and special treatment needed No data available |
FIRE-FIGHTING MEASURES | 5.1 Extinguishing media Suitable extinguishing media Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide. 5.2 Special hazards arising from the substance or mixture Carbon oxides, Nitrogen oxides (NOx) 5.3 Advice for firefighters Wear self-contained breathing apparatus for firefighting if necessary. 5.4 Further information No data available |
ACCIDENTAL RELEASE MEASURES | 6.1 Personal precautions, protective equipment and emergency procedures Use personal protective equipment. Avoid dust formation. Avoid breathing vapours, mist or gas. Ensure adequate ventilation. Evacuate personnel to safe areas. Avoid breathing dust. For personal protection see section 8. 6.2 Environmental precautions Prevent further leakage or spillage if safe to do so. Do not let product enter drains. 6.3 Methods and materials for containment and cleaning up Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed containers for disposal. 6.4 Reference to other sections For disposal see section 13 |
HANDLING AND STORAGE | 7.1 Precautions for safe handling Avoid contact with skin and eyes. Avoid formation of dust and aerosols.Avoid exposure - obtain special instructions before use. Provide appropriate exhaust ventilation at places where dust is formed. For precautions see section 2.2. 7.2 Conditions for safe storage, including any incompatibilities Store in cool place. Keep container tightly closed in a dry and well-ventilated place. Storage class (TRGS 510): Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects 7.3 Specific end use(s) Apart from the uses mentioned in section 1.2 no other specific uses are stipulated |
EXPOSURE CONTROLS/PERSONAL PROTECTION | 8.1 Control parameters Components with workplace control parameters 8.2 Exposure controls Appropriate engineering controls Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and at the end of workday. Personal protective equipment Eye/face protection Face shield and safety glasses Use equipment for eye protection tested and approved under appropriate government standards such as NIOSH (US) or EN 166(EU). Skin protection Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique (without touching glove's outer surface) to avoid skin contact with this product. Dispose of contaminated gloves after use in accordance with applicable laws and good laboratory practices. Wash and dry Hands Body Protection Complete suit protecting against chemicals, The type of protective equipment must be selected according to the concentration and amount of the dangerous substance at the specific workplace. Respiratory protection Where risk assessment shows air-purifying respirators are appropriate use a full-face particle respirator type N100 (US) or type P3 (EN 143) respirator cartridges as a backup to engineering controls. If the respirator is the sole means of protection, use a full-face supplied air respirator. Use respirators and components tested and approved under appropriate government standards such as NIOSH (US) or CEN (EU). Control of environmental exposure Prevent further leakage or spillage if safe to do so. Do not let product enter drains |
PHYSICAL AND CHEMICAL PROPERTIES | 9.1 Information on basic physical and chemical properties a) Appearance Form: powder Colour: white b) Odour No data available c) Odour Threshold No data available d) pH No data available e) Melting point/freezing point Melting point/range: 142 - 143 °C - lit. f) Initial boiling point and boiling range 267 - 268 °C - lit. g) Flash point No data available h) Evaporation rate No data available i) Flammability (solid, gas) No data available j) Upper/lower flammability or explosive limits No data available k) Vapour pressure 0,011 hPa at 50 °C - OECD Test Guideline 104 l) Vapour density No data available m) Relative density 1,09 g/cm3 at 20 °C - OECD Test Guideline 109 n) Water solubility 267 g/l at 20 °C o) Partition coefficient: noctanol/ water log Pow: 0,22 at 25 °C - OECD Test Guideline 107 p) Auto-ignition temperature No data available q) Decomposition temperature No data available r) Viscosity No data available s) Explosive properties No data available t) Oxidizing properties No data available 9.2 Other safety information No data available |
STABILITY AND REACTIVITY | 10.1 Reactivity No data available 10.2 Chemical stability Stable under recommended storage conditions. 10.3 Possibility of hazardous reactions No data available 10.4 Conditions to avoid No data available 10.5 Incompatible materials Strong oxidizing agents, acids, Acid chlorides, Acid anhydrides 10.6 Hazardous decomposition products Other decomposition products - No data available In the event of fire: see section 5 |
TOXICOLOGICAL INFORMATION | 11.1 Information on toxicological effects Acute toxicity LD50 Oral - Rat - male and female - 1.500 mg/kg (OECD Test Guideline 401) LD50 Dermal - Rat - male and female - > 2.000 mg/kg (OECD Test Guideline 402) Skin corrosion/irritation Skin - Rabbit Result: Causes burns. (OECD Test Guideline 404) Serious eye damage/eye irritation Eyes - Rabbit Result: Corrosive (OECD Test Guideline 405) Respiratory or skin sensitisation - Mouse Result: Does not cause skin sensitisation. (OECD Test Guideline 429) Germ cell mutagenicity Ames test Salmonella typhimurium Result: negative OECD Test Guideline 474 Mouse - male Result: negative Carcinogenicity Limited evidence of a carcinogenic effect. IARC: 2B - Group 2B: Possibly carcinogenic to humans (2-Methylimidazole) Reproductive toxicity Presumed human reproductive toxicant Specific target organ toxicity - single exposure No data available Specific target organ toxicity - repeated exposure No data available Aspiration hazard No data available Additional Information Repeated dose toxicity - Rat - male and female - Lowest observed adverse effect level - 100 mg/kg RTECS: NI7175000 burning sensation, Cough, wheezing, laryngitis, Shortness of breath, spasm, inflammation and edema of the larynx, spasm, inflammation and edema of the bronchi, pneumonitis, pulmonary edema, Material is extremely destructive to tissue of the mucous membranes and upper respiratory tract, eyes, and skin. To the best of our knowledge, the chemical, physical, and toxicological properties have not been thoroughly investigated |
ECOLOGICAL INFORMATION | 12.1 Toxicity Toxicity to fish static test LC50 - Pimephales promelas (fathead minnow) - 286 mg/l - 96 h Toxicity to daphnia and other aquatic invertebrates static test EC50 - Daphnia magna (Water flea) - 225,31 mg/l - 48 h Toxicity to algae static test EC50 - Desmodesmus subspicatus (Scenedesmus subspicatus) - 256,3 mg/l - 72 h Toxicity to bacteria EC50 - Pseudomonas putida - 459,9 mg/l - 7 h (DIN 38 412 Part 8) 12.2 Persistence and degradability Biodegradability aerobic - Exposure time 28 d Result: 67 % - Readily biodegradable (OECD Test Guideline 301B) 12.3 Bioaccumulative potential No data available 12.4 Mobility in soil No data available 12.5 Results of PBT and vPvB assessment This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher. 12.6 Other adverse effects No data available |
DISPOSAL CONSIDERATIONS | 13.1 Waste treatment methods Product Dissolve or mix the material with a combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber. Offer surplus and non-recyclable solutions to a licensed disposal company. Contaminated packaging Dispose of as unused product. |
TRANSPORT INFORMATION | 14.1 UN number ADR/RID: 3259 IMDG: 3259 IATA: 3259 14.2 UN proper shipping name ADR/RID: AMINES, SOLID, CORROSIVE, N.O.S. (2-Methylimidazole) IMDG: AMINES, SOLID, CORROSIVE, N.O.S. (2-Methylimidazole) IATA: Amines, solid, corrosive, n.o.s. (2-Methylimidazole) 14.3 Transport hazard class(es) ADR/RID: 8 IMDG: 8 IATA: 8 14.4 Packaging group ADR/RID: II IMDG: II IATA: II 14.5 Environmental hazards ADR/RID: no IMDG Marine pollutant: no IATA: no 14.6 Special precautions for user No data available |
REGULATORY INFORMATION | This safety datasheet complies with the requirements of Regulation (EC) No. 1907/2006. 15.1 Safety, health and environmental regulations/legislation specific for the substance or mixture 15.2 Chemical Safety Assessment For this product a chemical safety assessment was not carried out |
OTHER INFORMATION | The above information is believed to be correct but does not purport to be all inclusive and shall be used only as a guide. The information in this document is based on the present state of our knowledge and is applicable to the product with regard to appropriate safety precautions. It does not represent any guarantee of the properties of the product. For lab use only! |